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Abstract It has become increasingly clear in recent years that
amino acids can stimulate a signal transduction pathway
resulting in the phosphorylation of mammalian target of
rapamycin downstream targets. We have now found that amino
acid-dependent phosphorylation of p70S6 kinase and of S6 in
hepatocytes is prevented when AMP-dependent protein kinase
(AMPK) is activated by either the purine ribonucleoside
analogue AICAriboside, fructose or glycerol. Insulin-dependent
phosphorylation of protein kinase B is not affected by AMPK
activation. Protein synthesis is strongly inhibited when AMPK is
activated. It is concluded that amino acid-dependent signaling, a
protein-anabolic signal, can be effectively antagonized by
activation of AMPK. ) 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Recent research, initiated by our laboratory [1], has dem-
onstrated that amino acids, in addition to their role as inter-
mediary metabolites, can stimulate mammalian target of ra-
pamycin (mTOR)-dependent phosphorylation of signal
transduction components which also participate in insulin sig-
naling [2^4]. Although in various cell types insulin alone can
stimulate PI 3-kinase-dependent phosphorylation of protein
kinase B (PKB), the hormone cannot activate mTOR down-
stream targets unless low concentrations of certain amino
acids, leucine in particular, are also present. By contrast,
high concentrations of amino acids stimulate phosphorylation
of mTOR downstream targets in the absence of insulin but do
not e¡ect PKB and, presumably, also do not a¡ect PI 3-kinase
although the latter issue is controversial [4]. The mechanism
by which amino acids stimulate mTOR-mediated signaling is
not known but a possibility is that they either directly, or
indirectly, stimulate mTOR activity or that they inhibit a pro-
tein phosphatase acting on mTOR and/or mTOR downstream
targets ([4], for review).
It is now generally accepted that mTOR functions as an
amino acid sensor, not only in mammalian cells but also in
yeast, controlling protein synthesis and degradation in a re-
ciprocal fashion [3,5]. In an elegant study with HEK293 cells,
Dennis et al. [6] proposed that mTOR may also act as a
sensor of intracellular ATP concentration. It was noted that
among the various protein kinases, the Km of mTOR for ATP
in vitro was exceptionally high and within the physiological
(mM) range of ATP concentrations. Moreover, by inhibition
of either mitochondrial or glycolytic ATP production in intact
cells, a correlation was found between intracellular ATP levels
and the degree of phosphorylation of p70S6 kinase or 4E-
BP1, as indicators of in situ mTOR activity. Because inhibi-
tion of ATP production may also a¡ect AMP levels via the
adenylate kinase equilibrium [7^9], we investigated whether
activation of AMP-dependent protein kinase (AMPK), which
shuts o¡ ATP-dependent pathways [10], may also contribute
to mTOR inhibition. Our data, obtained with isolated hepa-
tocytes, indicate that this is, indeed, the case.
2. Materials and methods
2.1. Materials
Insulin, rapamycin, AICAR (AICAriboside, imidazole-4-carboxam-
ide 1-L-D-ribofuranoside) and the chemicals for enhanced chemilumi-
nescence (ECL) were from Sigma (St. Louis, MO, USA). LY294002
(2-(4-morpholinyl)-8-phenylchromone) was obtained from Biomol
(Plymouth Meeting, PA, USA). Phosphospeci¢c anti-PKB (Thr308)
was from New England Biolabs. Phosphospeci¢c anti-AMPK
(Thr172) was from Cell Signaling Technology Inc. (Leusden, The
Netherlands). Rabbit anti-p70S6 kinase was from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). Goat anti-rabbit horseradish peroxi-
dase was from Bio-Rad (Hercules, CA, USA). Silicone oil AR200 was
from Wacker-Chemie GmbH (Burghausen, Germany). [32P]Phosphate
and [3H]valine were from Amersham Corp. (’s Hertogenbosch, The
Netherlands). All other chemicals and enzymes were obtained from
either Boehringer (Mannheim, Germany) or Sigma (St. Louis, MO,
USA).
Rapamycin and LY294002 were dissolved in dimethyl sulphoxide
(DMSO). The ¢nal DMSO concentration did not exceed 0.25% (v/v).
This concentration of DMSO did not a¡ect the processes that were
studied.
2.2. Preparation of hepatocytes
Hepatocytes were isolated from 16 to 20 h starved male Wistar rats
(200^250 g) by collagenase perfusion [11].
2.3. Hepatocyte incubation
Hepatocytes (5^10 mg dry weight/ml) were pre-incubated for the
indicated time periods at 37‡C in minimal medium (Krebs^Henseleit
bicarbonate bu¡er plus 10 mM Na^HEPES, pH 7.4, and 20 mM
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glucose). In all experiments, hepatocytes were ¢rst incubated in this
medium for 20 min to allow for temperature adjustment. This was
then followed by addition of the components as indicated in the
legends. Final incubation volume was 2^3 ml. The gas atmosphere
was O2/CO2 (19:1, v/v).
For measurement of S6 phosphorylation, hepatocytes were ¢rst
loaded with [32P]phosphate (50 WCi/ml), exactly as described in [1].
Protein synthesis was measured with [3H]valine (0.5 WCi/ml), as in
[1]. In order to ensure uniformity of the labeling of the intracellular
valine pool, a concentration of 5 mM valine was used.
The composition of the complete mixture of all amino acids (4xAA)
used in the experiments was such that the concentration of each of the
amino acids was present at a concentration four times that found in
the portal vein of a fasted rat. The composition of the 1xAA mixture
was exactly as described in [11] except that the leucine concentration
was 250 WM.
At the end of the incubations, hepatocytes were collected for gel
analysis by centrifugation in 5 volumes of an ice-cold solution of
150 mM NaCl plus 10 mM Na^HEPES (pH 7.4) for 5 s in an
Eppendorf centrifuge. For the SDS^PAGE procedures, the pellet
was lysed by addition of Laemmli sample bu¡er and subsequently
incubated at 95‡C for 5 min. Cells for determination of ATP were
centrifuged in a microcentrifuge through a layer of silicone oil into a
layer of 14% (m/v) HClO4. The acidi¢ed samples underneath the oil
were re-extracted by stirring, centrifuged again and neutralized to
pH 7 with a small volume of a mixture of 2 M KOH plus 0.3 M
MOPS.
2.4. Gel retardation assay
An equivalent of 40^60 Wg of cell protein per sample was separated
by SDS^PAGE. For separation of the di¡erent phosphorylated forms
of p70S6 kinase a 7.5% (w/v) polyacrylamide gel was used. After
separation, a standard Western blotting procedure was performed
and the blot was incubated with an antibody against p70S6 kinase.
The proteins were visualized by ECL.
2.5. Phosphorylation of PKB and of AMPK
An equivalent of 30^40 Wg of cell protein per sample was separated
by 10% (w/v) SDS^PAGE. After separation, a standard Western blot-
ting procedure was performed. The blot was subsequently incubated
with an antibody against the phosphorylated form of PKB (Thr308) or
against the phosphorylated form of AMPK (Thr172). ECL was per-
formed to visualize the proteins.
2.6. Phosphorylation of S6
An equivalent of 100 Wg of cell protein per sample was separated by
10% (w/v) SDS^PAGE. Gel slabs were dried and subjected to auto-
radiography. Protein phosphorylation was quanti¢ed with a Phos-
phorImager (Molecular Dynamics, Sunnyvale, CA, USA).
2.7. Determination of ATP
ATP was determined £uorimetrically with NADPþ, glucose, hexo-
kinase and glucose 6-phosphate dehydrogenase [12].
2.8. Statistics
The data are summarized as meansQS.E.M., with the number of
di¡erent hepatocyte preparations in parentheses (Fig. 2). Statistical
signi¢cance was determined using Student’s t-test (P6 0.05).
3. Results
3.1. E¡ect of AMPK activation on p70S6 kinase and S6
phosphorylation
The e¡ect of AMPK activation on amino acid-dependent
signaling was studied by titrating AICAR, a speci¢c activator
of AMPK [13], in the presence of amino acids. Phosphoryla-
tion of AMPK at Thr172, which has been shown to parallel its
activity [14,15], was maximal at 250 WM AICAR (Fig. 1A).
Neither the absence of amino acids nor the presence of rapa-
mycin, an inhibitor of mTOR activation, a¡ected basal
AMPK phosphorylation. Phosphorylation of p70S6 kinase
greatly increased upon addition of amino acids (in agreement
with existing literature; [4], for review); the e¡ect was com-
pletely prevented by rapamycin and also counteracted by AI-
CAR at concentrations similar to those required for activation
of AMPK, AICAR being maximally e¡ective at a concentra-
tion of 250 WM (Fig. 1B). In order to demonstrate that activ-
ity of p70S6 kinase was also diminished by AICAR, its e¡ect
on amino acid-stimulated phosphorylation of ribosomal pro-
tein S6, a measure of the in situ activity of p70S6 kinase [16],
was also studied. Similar to p70S6 kinase, phosphorylation of
S6 was stimulated by amino acid addition in a rapamycin-
sensitive manner (cf. [1]), and this was prevented by AICAR
(Fig. 1C).
AMPK could also be activated by addition of either fruc-
tose (cf. [17]) or glycerol. In hepatocytes, these two com-
pounds are rapidly phosphorylated and decrease intracellular
ATP because of intracellular phosphate depletion [18,19] (Ta-
ble 1). Like AICAR, both fructose and glycerol increased
AMPK phosphorylation and antagonized amino acid-depen-
dent stimulation of p70S6 kinase and S6 phosphorylation
(Fig. 1A^C).
It is important to stress that intracellular ATP was not
a¡ected by AICAR (in agreement with [13]) nor was it in£u-
enced by amino acid depletion or rapamycin addition (Table 1).
3.2. E¡ect of AMPK activation on PKB phosphorylation
In another series of experiments we tested the e¡ect of
AICAR on PKB phosphorylation. In these experiments, in-
sulin had to be used to stimulate PKB phosphorylation be-
cause amino acids do not a¡ect PKB ([4], for review).
In contrast to amino acid-dependent stimulation of p70S6
kinase and S6 phosphorylation, insulin-dependent stimulation
of PKB phosphorylation was not a¡ected by AICAR
(Fig. 1D). As a control, the e¡ect of the PI 3-kinase inhibitor
LY294002 was also tested. As expected, this compound
completely prevented insulin-dependent phosphorylation of
PKB (Fig. 1D). The lack of inhibition of insulin-stimulated
PKB phosphorylation by activation of AMPK is in agreement
with similar observations in other cell types [20,21].
3.3. Inhibition of protein synthesis by AMPK activation
Because mTOR downstream targets are involved in the reg-
ulation of protein synthesis [2,3,5,6], the e¡ect of AMPK ac-
tivation on protein synthesis was investigated and compared
with the e¡ect of rapamycin. Protein synthesis was two-fold
stimulated by the presence of amino acids, was completely
inhibited by cycloheximide and strongly inhibited by AMPK
activation, whether induced by AICAR or fructose (Fig. 2).
The strong inhibition of hepatic protein synthesis by fructose
con¢rms existing literature [18]. Rapamycin inhibited protein
synthesis by 20% only (cf. [1]).
Table 1
Intracellular ATP
Additions ATP (Wmol/g dry weight)
None 12.8Q 0.4 (5)
4AA 12.7Q 0.3 (5)
4AA+AICAR 250 WM 12.1Q 0.4 (5)
4AA+fructose 15 mM 2.6Q 0.7 (4)a
4AA+glycerol 10 mM 6.6Q 0.4 (4)a
4AA+rapamycin 100 nM 11.9Q 0.6 (3)
Hepatocytes were incubated as described in the legend to Fig. 1.
aSigni¢cantly di¡erent from the control in the presence of amino
acids alone (P6 0.05).
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4. Discussion
In hepatocytes, mTOR-mediated signaling can be stimu-
lated by either a combination of insulin and low concentra-
tions of amino acids acting in synergy, or by high concentra-
tions of amino acids alone [1,4]. The interference of AMPK
with signaling appears to be con¢ned to amino acid-depen-
dent, mTOR-mediated signaling because insulin-stimulated
PKB phosphorylation was not a¡ected.
It has recently been demonstrated that mTOR activity is
kinetically controlled by the cytosolic ATP concentration,
and it was proposed that mTOR, in addition to its function
as a sensor of amino acids, is also a sensor of ATP [6]. Our
data strongly suggest that AMPK is an additional element in
the control of mTOR-dependent signaling. In this context, the
recent observation that mTOR is associated with the mito-
chondrial outer membrane [22] is highly relevant, because ade-
nylate kinase, which controls AMP concentration, is predom-
Fig. 1. Phosphorylation of AMPK (A), p70S6 kinase (B), S6 (C) and PKB (D). Hepatocytes were preincubated for 15 min in the absence or
presence of AICAR (at the concentrations indicated in WM), 100 nM rapamycin, 15 mM fructose, or 10 mM glycerol; amino acids (4xAA; dis-
solved in the minimal incubation medium) were then added and incubation was continued for another 30 min. When amino acids were not
present, the same protocol was followed except that an equivalent volume of minimal medium without amino acids was added to the cell sus-
pension. In D, insulin (1037 M) was added 4 min before the end of the incubation. The data are from experiments carried out with four di¡er-
ent hepatocyte preparations. Fig. 1B is a representative experiment. Data (A,C,D) are expressed as fold increase over the control value. Abbre-
viations: rapa, rapamycin; ins, insulin; LY, LY294002.
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inantly located in the mitochondrial intermembrane space and
is not present in the mitochondrial matrix [23]. mTOR is thus
in a perfect position to be controlled by changes in ATP/AMP
ratio.
Clearly, the strong inhibitory e¡ect of AMPK activation on
protein synthesis cannot solely be ascribed to an e¡ect on
mTOR-dependent signaling, because inhibition of protein syn-
thesis by rapamycin was much less e¡ective (Fig. 2). Appar-
ently, AMPK inhibits protein synthesis not only through in-
hibition of mTOR-mediated signaling but also at other steps
controlling the protein synthesizing machinery.
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Fig. 2. Protein synthesis. Hepatocytes were incubated for 1 h in the
absence or presence of the amino acid mixture (4xAA). The concen-
tration of valine was 5 mM under all conditions. Where present, 10
WM cycloheximide, 100 nM rapamycin, 15 mM fructose or AICAR
(at the indicated concentrations in WM) were added. Data are the
meansQS.E.M. from experiments carried out with four to six hepa-
tocyte preparations. Values represent the amount of [3H]valine in-
corporated into protein. With fructose, only two experiments were
carried out. *, Signi¢cantly di¡erent from the corresponding control
in the presence of amino acids alone; **, signi¢cantly di¡erent from
the control in the absence of amino acids. Abbreviations: rapa, ra-
pamycin; CH, cycloheximide.
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